Compare ARK Genomic Revolution ETF (ARKG) vs ArcelorMittal SA (MT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs ArcelorMittal SA — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while ArcelorMittal SA trades at $66.55 (market cap $49.99B). The key difference: ArcelorMittal SA pays a 0.91% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | MT | |
|---|---|---|
Sector | Sector/Thematic | Basic Materials |
52-Week High | $43.57 | $71.65 |
52-Week Low | $23.09 | $30.39 |
Market Cap | — | $49.99B |
Enterprise Value | — | $59.31B |
Dividend Yield | — | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ArcelorMittal (MT) trades at $66.08, up 4.96% today, with strong earnings beats in recent quarters. The stock shows bullish momentum with a 41% gain over six months, supported by record iron ore shipments and strategic expansions. Valuation ratios appear reasonable with P/E at 17.3 and P/B below 1. Technical indicators are mixed, with moving averages bullish but oscillators neutral. Recent news highlights CEO transitions in Europe and a new share buyback program.
Outlook remains positive due to operational strength and shareholder returns, but risks include heavy capital expenditure and China demand weakness. Analyst consensus is bullish with 50% buy ratings. The stock's performance hinges on continued execution amid global steel market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →
